PATENT CLAIM ANALYSIS

Application Number: 16248912
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "04400A"]

Abstract:
TNFα antisense oligonucleotides are provided herein. Methods of treating TNFα diseases or disorders using the TNFα antisense oligonucleotides and related products are provided.

Claim (Index 79):
The method of  claim 64 , wherein the oligonucleotide further comprises a molecular species at least one of: the 3\u2032 and the 5\u2032 end.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 99.0
- Lexical Diversity: 1.38889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15517064', '10644052', '14114471', '11748422', '12952863']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7667007528926147
- 35 USC 102 Novelty (BERT): 0.6103664674254298
- Combined Prediction Score: 0.7510673243458962
- Mean Citation Score: 328.277526
- Max Citation Score: 593.3532
- Similarity Product: 450.0468608030319

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test